Naihan Xu
Overview
Explore the profile of Naihan Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
2387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu Y, Liu Q, Liao M, Diao L, Wu T, Liao W, et al.
Mol Ther Nucleic Acids
. 2024 Dec;
36(1):102411.
PMID: 39719982
No abstract available.
2.
Feng Y, Zhang Z, Zhang H, Guo H, Tan C, Xu N, et al.
ACS Pharmacol Transl Sci
. 2024 Dec;
7(12):3945-3954.
PMID: 39698261
Breast cancer with positive expression of estrogen receptor α (ERα+) accounts for 70% of breast cancer cases, whose predominant treatment is currently endocrine therapy. The main strategy of endocrine therapy...
3.
Wang R, Li X, Jiang Y, Zhang H, Yang S, Xie W, et al.
Inflammation
. 2024 Nov;
PMID: 39503963
Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide and poses a significant threat to human health. Recent studies have underscored the crucial role of aberrant expression of...
4.
Chen H, Zhuang Z, Xu N, Feng Y, Fang K, Tan C, et al.
Biosensors (Basel)
. 2024 Mar;
14(3).
PMID: 38534242
The ongoing COVID-19 pandemic, driven by persistent SARS-CoV-2 transmission, threatens human health worldwide, underscoring the urgent need for an efficient, low-cost, rapid SARS-CoV-2 detection method. Herein, we developed a point-of-care...
5.
Liao M, Liao W, Xu N, Li B, Liu F, Zhang S, et al.
EBioMedicine
. 2024 Mar;
102:105084.
PMID: 38518654
No abstract available.
6.
Xue X, Zhang C, Li X, Wang J, Zhang H, Feng Y, et al.
MedComm (2020)
. 2024 Feb;
5(2):e478.
PMID: 38374873
Proteolysis-targeting chimeras (PROTACs) are essential bifunctional molecules that target proteins of interest (POIs) for degradation by cellular ubiquitination machinery. Despite significant progress made in understanding PROTACs' functions, their therapeutic potential...
7.
Chen H, Feng Y, Liu F, Tan C, Xu N, Jiang Y, et al.
Biosens Bioelectron
. 2023 Dec;
247:115929.
PMID: 38128320
The clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein (Cas) (CRISPR/Cas) system enables sensitive and specific detection of biomolecules, thanks to its programmability, high fidelity, and powerful signal amplification capabilities....
8.
Sun Y, Jiang L, Zhang Z, Xu N, Jiang Y, Tan C
ACS Appl Mater Interfaces
. 2023 Dec;
PMID: 38108633
Nucleic acid-based therapeutics have gained increasing attention due to their ability to regulate various genetic disorders. However, the safe and effective delivery of nucleic acids to their intended cellular sites...
9.
Li H, Hou Z, Wang Y, Zhou Z, Cai J, Xin Q, et al.
Biochem Biophys Rep
. 2023 Jul;
35:101508.
PMID: 37448811
Peptides can be used as effective molecular tool for covalent modification of proteins and play important roles in ligand directed covalent modification. Tyr-selective protein modifications exert a profound impact on...
10.
Jiang Y, Xu N
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298636
Neurodegenerative diseases (NDDs) have become a significant global public health problem and a major societal burden. The World Health Organization predicts that NDDs will overtake cancer as the second most...